EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis
Abstract
Authors
CW Lin R Wang E Tzeng
CW Lin R Wang E Tzeng
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now